Related Experiment Video
Updated: Jan 9, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection
Ferran Tarrés-Freixas1, Benjamin Trinité1, Jorge Carrillo1,2
1IrsiCaixa, Ctra del Canyet S/N., 08916 Badalona, Spain.
Human Immunodeficiency Virus (HIV) causes AIDS by infecting CD4 T cells. Despite advances in antiretroviral drugs, a vaccine remains elusive due to viral variability, necessitating better tool deployment.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Human Immunodeficiency Virus (HIV), the cause of Acquired Immunodeficiency Syndrome (AIDS), emerged from zoonotic spillover events.
- HIV infects and destroys CD4 T cells, crucial for adaptive immunity, leading to immune system collapse.
- The virus's high genetic variability, especially in its envelope glycoprotein, hinders vaccine development.
Purpose of the Study:
- To summarize the current understanding of HIV pathogenesis, treatment, and prevention challenges.
- To highlight the impact of HIV on global health and the limitations of current interventions.
- To emphasize the need for improved strategies in combating the HIV/AIDS epidemic.
Main Methods:
- Review of scientific literature on HIV virology, immunology, and epidemiology.
- Analysis of the challenges in developing an effective HIV vaccine.
- Assessment of the successes and limitations of antiretroviral therapy.
- Examination of the global burden and transmission dynamics of HIV/AIDS.
Main Results:
- HIV's reverse transcriptase enables high sequence variability, complicating vaccine and treatment efforts.
- Antiretroviral drugs are effective in managing HIV but do not eradicate the virus due to latent reservoirs.
- Despite 40 years of research, an effective HIV vaccine has not been developed.
- HIV has infected over 90 million people and caused 44 million deaths globally.
Conclusions:
- Current antiretroviral therapies save lives but cannot eliminate HIV due to latent reservoirs.
- The development of an effective HIV vaccine remains a significant challenge.
- Improved deployment of existing preventative and therapeutic tools is crucial, especially in high-incidence areas.
- A comprehensive approach combining prevention, treatment, and ongoing research is essential to control the HIV/AIDS pandemic.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Retrovirus Life Cycles
Viruses with RNA Genomes
Mechanisms of Retrovirus-induced Cancers
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

